BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3180577)

  • 21. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells.
    Park J; Gelse K; Frank S; von der Mark K; Aigner T; Schneider H
    J Gene Med; 2006 Jan; 8(1):112-25. PubMed ID: 16142704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of bone morphogenetic protein-induced bone and cartilage formation on a new carrier: fibrous collagen membrane.
    Shigenobu K; Kaneda K; Nagai N; Kuboki Y
    Ann Chir Gynaecol Suppl; 1993; 207():85-90. PubMed ID: 8154842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction.
    Kaps C; Bramlage C; Smolian H; Haisch A; Ungethüm U; Burmester GR; Sittinger M; Gross G; Häupl T
    Arthritis Rheum; 2002 Jan; 46(1):149-62. PubMed ID: 11817587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family.
    Wolfman NM; Hattersley G; Cox K; Celeste AJ; Nelson R; Yamaji N; Dube JL; DiBlasio-Smith E; Nove J; Song JJ; Wozney JM; Rosen V
    J Clin Invest; 1997 Jul; 100(2):321-30. PubMed ID: 9218508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone formation under the influence of bone morphogenetic protein/self-setting apatite cement composite as a delivery system.
    Kamegai A; Shimamura N; Naitou K; Nagahara K; Kanematsu N; Mori M
    Biomed Mater Eng; 1994; 4(4):291-307. PubMed ID: 7950877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro proteoglycan synthesis in response to extracts of demineralized bone.
    Nathanson MA
    Clin Orthop Relat Res; 1994 Feb; (299):263-81. PubMed ID: 8119030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogenic bone and cartilage morphogenesis. Rat BMP in vivo and in vitro.
    Kübler N; Urist MR
    J Craniomaxillofac Surg; 1991 Oct; 19(7):283-8. PubMed ID: 1836472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of tenascin in joint-associated tissues during development and postnatal growth.
    Mackie EJ; Ramsey S
    J Anat; 1996 Feb; 188 ( Pt 1)(Pt 1):157-65. PubMed ID: 8655402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of partially purified bone morphogenetic protein on DNA synthesis and cell replication in calvarial and fibroblast cultures.
    Canalis E; Centrella M; Urist MR
    Clin Orthop Relat Res; 1985 Sep; (198):289-96. PubMed ID: 4028562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplant of bone marrow and muscle-derived connective tissue cultures in diffusion chambers for bioassay of bone morphogenetic protein.
    Kataoka H; Urist MR
    Clin Orthop Relat Res; 1993 Jan; (286):262-70. PubMed ID: 8425356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.
    Scharstuhl A; Vitters EL; van der Kraan PM; van den Berg WB
    Arthritis Rheum; 2003 Dec; 48(12):3442-51. PubMed ID: 14673995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.
    Gitelman SE; Kirk M; Ye JQ; Filvaroff EH; Kahn AJ; Derynck R
    Cell Growth Differ; 1995 Jul; 6(7):827-36. PubMed ID: 7547504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6.
    Hennig T; Lorenz H; Thiel A; Goetzke K; Dickhut A; Geiger F; Richter W
    J Cell Physiol; 2007 Jun; 211(3):682-91. PubMed ID: 17238135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer.
    Aono A; Hazama M; Notoya K; Taketomi S; Yamasaki H; Tsukuda R; Sasaki S; Fujisawa Y
    Biochem Biophys Res Commun; 1995 May; 210(3):670-7. PubMed ID: 7763240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts.
    Zhou H; Hammonds RG; Findlay DM; Martin TJ; Ng KW
    J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line.
    Valcourt U; Ronzière MC; Winkler P; Rosen V; Herbage D; Mallein-Gerin F
    Exp Cell Res; 1999 Sep; 251(2):264-74. PubMed ID: 10471312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related changes of cell outgrowth from rat calvarial and mandibular bone in vitro.
    Cei S; Mair B; Kandler B; Gabriele M; Watzek G; Gruber R
    J Craniomaxillofac Surg; 2006 Oct; 34(7):387-94. PubMed ID: 17055735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of callus formation by implants of bone morphogenetic protein and associated bone matrix noncollagenous proteins.
    Kawamura M; Urist MR
    Clin Orthop Relat Res; 1988 Nov; (236):240-8. PubMed ID: 3180578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone matrix-directed chondrogenesis of muscle in vitro.
    Nathanson MA
    Clin Orthop Relat Res; 1985 Nov; (200):142-58. PubMed ID: 3905106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell differentiation in response to partially purified osteosarcoma-derived bone morphogenetic protein in vivo and in vitro.
    Kübler N; Urist MR
    Clin Orthop Relat Res; 1993 Jul; (292):321-8. PubMed ID: 8519127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.